Table 3: Efficacy analysis of MCG-1 subtypes in cohort-1 and the Oncomine-dataset.
Cohort-1 | |||||
---|---|---|---|---|---|
Metastasis | CSS Indicator (+ = Death due to BC ) | ||||
Efficacy analysis | Efficacy analysis | ||||
AUC | % Sensitivity | % Specificity | AUC | % Sensitivity | % Specificity |
0.545 | 80.0 | 30.8 | 0.586 | 83.3 | 35.7 |
Bootstrap modeling | Bootstrap modeling | ||||
Mean | 63.9 | 57.7 | Mean | 69.5 | 54.7 |
Median | 68.0 | 56.3 | Median | 78.9 | 50 |
95% CI | 17.9 – 95.8 | 23.1 – 100 | 95% CI | 18.2 – 98.3 | 20.0 – 100 |
Oncomine-dataset | |||||
CSS Indicator | OS Indicator (+ = Death) | ||||
Efficacy analysis | Efficacy analysis | ||||
AUC | % Sensitivity | % Specificity | AUC | % Sensitivity | % Specificity |
0.516 | 52.2 | 56.4 | 0.571 | 55.3 | 58.3 |
Bootstrap modeling | Bootstrap modeling | ||||
Mean | 67.8 | 46.4 | Mean | 60.2 | 57.3 |
Median | 66.7 | 49.0 | Median | 58.7 | 60.7 |
95% CI | 25.0 – 90.1 | 21.3 – 85.9 | 95% CI | 13.4 – 96.0 | 14.9 – 99.3 |